HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Buynak Selected Research

Low Back Pain (Lumbago)

11/2015Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.
8/2010Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Buynak Research Topics

Disease

2Pain (Aches)
11/2015 - 08/2010
2Low Back Pain (Lumbago)
11/2015 - 08/2010
1Infections
05/2016
1Chronic Pain
11/2015
1Knee Osteoarthritis
11/2015
1Osteoarthritis
11/2015
1Nausea
08/2010
1Vomiting
08/2010
1Constipation
08/2010

Drug/Important Bio-Agent (IBA)

2Oxycodone (Oxycontin)FDA LinkGeneric
11/2015 - 08/2010
2TapentadolFDA Link
11/2015 - 08/2010
1faldaprevirIBA
05/2016
1Ribavirin (Virazole)FDA LinkGeneric
05/2016